References

  1. Cohen M, Baldin B, Thomas P, Lebrun C. Evènements neurologiques sous traitement par anti-TNF alpha. Revue Neurologique. 2012 Jan;168(1):33-9. PubMed | Google Scholar

  2. Singer OC, Otto B, Steinmetz H, Ziemann U. Acute neuropathy with multiple conduction blocks after TNF-alpha monoclonal antibody therapy. Neurology. 2004 Nov 9;63(9):1754. PubMed | Google Scholar

  3. Rodriguez-Escalera C, Belzunegui J, Lopez-Dominguez L, Gonzalez C, Figueroa M. Multifocal motor neuropathy with conduction block in a patient with rheumatoïd arthritis on infliximab therapy. Rheumatology (Oxford). 2005; 44: 132-133. Google Scholar

  4. Cocito D, Bergamasco B, Tavella A et al. Multifocal motor neuropathy during treatment with infliximab. J Peripher Nerv Syst. 2005 Dec;10(4):386-7. PubMed | Google Scholar

  5. Richette P, Dieude P, Damiano J, Liote F, Orcel P, Bardin T. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoïd arthritis. J Rheumatol. 2004;31: 2079-2081. Google Scholar

  6. Richez C, Blanco P, Lagueny A, Schaeverbeke T, Dehais J. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology. 2005 Apr 26;64(8):1468-70. PubMed | Google Scholar

  7. Tektonidou MG, Serelis J, Skopouli FN. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment. Clin Rheumatol. 2007 Feb;26(2):258-60. PubMed | Google Scholar

  8. Ramos-Casals M, Brito-Zeron P, Mu˜noz S et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007 Jul;86(4):242-51 Google Scholar

  9. Hamon MA, Nicolas G, Deviere F, Letournel F, Dubas F. Neuropathie démyélinisante au cours d’un traitement par anti-TNF alpha et revue de la littérature Rev Neurol. 2007 Dec;163(12):1232-5. PubMed | Google Scholar

  10. Stubgen J. Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve. 2008; 37(3):281-92. PubMed | Google Scholar